Image de couverture de livre

Allergic bronchopulmonary aspergillosis treated successfully with omalizumab

Fuente: Redalyc

Enregistré dans:

Détails bibliographiques
Auteur principal:	R. Aguiar
Format:	Artículo científico
Langue:	en
Publié:	Sociedade Portuguesa de Pneumologia 2017
Sujets:	Medicina
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”
par: Kai‐Yen Chang, et autres
Publié: (2024)

Reply to Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—factor analysis”
par: Naoki Okada, et autres
Publié: (2024)

Allergic bronchopulmonary aspergillosis complicated by nontuberculous mycobacteria infection in a child: An uncommon but treatable condition
par: Yilijang Tuhongjiang, et autres
Publié: (2024)

Development of allergic bronchopulmonary aspergillosis in a patient with nontuberculous mycobacterial‐pulmonary disease successfully treated with dupilumab: A case report and literature review
par: Ryuta Onozato, et autres
Publié: (2024)

Efficacy of dupilumab as an alternative to corticosteroids in the treatment of exacerbations of allergic bronchopulmonary aspergillosis
par: Masamitsu Hamakawa, et autres
Publié: (2024)

Asthma control and exacerbations in patients with severe asthma treated with omalizumab in Portugal
par: A.S. Sousa
Publié: (2015)

A case of Morbihan syndrome successfully treated with high dose omalizumab
par: Theng Chun Wong, et autres
Publié: (2025)

Population prevalence of aspergillus sensitization and allergic bronchopulmonary aspergillosis in COPD subjects in North India
par: Kathirvel Soundappan, et autres
Publié: (2024)

Allergic broncho‐pulmonary aspergillosis: Old disease, new frontiers
par: Eve Denton, et autres
Publié: (2024)

Cholinergic pruritus treated with omalizumab: Seven cases
par: Alice Bréhon, et autres
Publié: (2024)

Endobronchial aspergilloma: An unusual presentation of pulmonary aspergillosis
par: D. Araújo
Publié: (2016)

Pulmonary aspergillosis: a challenging condition in the whole world
par: Vitorino Modesto dos Santos
Publié: (2021)

Severe bronchopulmonary dysplasia with large pneumatoceles in an extreme preterm newborn
par: G. Rocha
Publié: (2017)

Indeterminate cell histiocytosis successfully treated with phototherapy
par: Maria Claudia Nogueira Zerbini
Publié: (2016)

Invasive pulmonary aspergillosis with brain dissemination in an immunocompetent host
par: Senthil Kumar
Publié: (2021)

Progestogen hypersensitivity: successful use of progesterone desensitisation and omalizumab to facilitate in vitro fertilisation
par: Gary Xu, et autres
Publié: (2024)

Disseminated invasive aspergillosis in a prolonged stay in the intensive care unit
par: Gajender Singh
Publié: (2017)

The grim reaper evading modern medicine: aspergillosis, adenovirus, and Hodgkin lymphoma
par: Larry Nichols
Publié: (2020)

COVID-19 associated pulmonary aspergillosis (CAPA) in a pregnant woman
par: Shruti Agrawal
Publié: (2021)

A case of cow's milk allergy treated with rush oral immunotherapy with omalizumab
par: Yasushi Iwasaki, et autres
Publié: (2024)

Allergic bronchopulmonary mycosis in Schizophyllum commune with positive Aspergillus‐specific IgE antibodies: A case report
par: Hiroshi Takahashi, et autres
Publié: (2024)

Seasonal omalizumab reduces allergen-specific immunoglobulin E levels in patients with Japanese cedar pollinosis and asthma
par: S. Hamada
Publié: (2017)

Conidial heads (Fruiting Bodies) as a hallmark for histopathological diagnosis of angioinvasive aspergillosis
par: Luciana Depiere Lanzarin
Publié: (2015)

Experiência clínica com omalizumab na consulta de asma grave
par: S. Alfarroba
Publié: (2014)

Model‐based meta‐analysis of omalizumab in treating patients with chronic idiopathic/spontaneous urticaria
par: Aiping Zhao, et autres
Publié: (2024)

Real-life efficacy and safety of omalizumab in Portuguese patients with persistent uncontrolled asthma
par: M. Pereira Barbosa
Publié: (2015)

Does omalizumab impair glucose homeostasis in a patient with severe persistent asthma and type 2 diabetes mellitus?
par: S. Hamada
Publié: (2017)

Severe digital ischemia due to systemic sclerosis successfully treated with bosentan: case report
par: Cesar José Guimarães Soares
Publié: (2007)

Calidad de vida en pacientes con asma alérgica severa en tratamiento con omalizumab
par: Nadia Karina Aguilar-Hinojosa
Publié: (2018)

Experiencia clínica con omalizumab en pacientes con asma severa. Datos del mundo real
par: Jorge Bernardo Vargas-Correa
Publié: (2016)

A successful case of anti-NMDAR encephalitis without tumor treated with a prolonged regimen of plasmapheresis
par: Mateus Mistieri Simabukuro
Publié: (2014)

Characterization of Allergic Manifestations in Dental Professionals
par: Jorge Oviedo-Quirós
Publié: (2022)

The use of omalizumab in food allergy
par: Shifaa Alkotob, et autres
Publié: (2024)

Estudio observacional retrospectivo de la utilización de omalizumab en el tratamiento del asma grave persistente
par: Núria Padullés Zamora
Publié: (2013)

Eficacia a largo plazo del omalizumab en pacientes con queratoconjuntivitis vernal resistente a tratamiento convencional
par: Luis Santamaría
Publié: (2018)

Pachydermoperiostosis successfully treated with celecoxib
par: Hiroki Yamamoto, et autres
Publié: (2025)

A case of allergic bronchopulmonary mycosis: 3D‐CT Findings led to successful multidisciplinary treatment with dupilumab and cryoprobe
par: Masamitsu Hamakawa, et autres
Publié: (2024)

Urticaria por frío y riesgo de anafilaxia tratada con omalizumab. A propósito de un caso
par: Tonatiuh Ramsés Bedolla-Pulido
Publié: (2020)

Outpatient inhaled corticosteroid use in bronchopulmonary dysplasia
par: Cynara Leon, et autres
Publié: (2024)

Efectividad y análisis farmacoeconómico del tratamiento del asma grave con omalizumab en la práctica clínica
par: Eva Martínez-Moragón
Publié: (2019)